BAM
Bullseye Asset Management’s AbCellera Biologics ABCL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-17,766
| Closed | -$134K | – | 71 |
|
|
2023
Q1 | $134K | Hold |
17,766
| – | – | 0.07% | 72 |
|
|
2022
Q4 | $180K | Hold |
17,766
| – | – | 0.1% | 76 |
|
|
2022
Q3 | $176K | Hold |
17,766
| – | – | 0.1% | 80 |
|
|
2022
Q2 | $189K | Hold |
17,766
| – | – | 0.11% | 82 |
|
|
2022
Q1 | $173K | Hold |
17,766
| – | – | 0.08% | 85 |
|
|
2021
Q4 | $254K | Sell |
17,766
-10,048
| -36% | -$144K | 0.1% | 88 |
|
|
2021
Q3 | $557K | Buy |
27,814
+515
| +2% | +$10.3K | 0.19% | 89 |
|
|
2021
Q2 | $600K | Hold |
27,299
| – | – | 0.2% | 86 |
|
|
2021
Q1 | $927K | Buy |
27,299
+10,000
| +58% | +$340K | 0.35% | 81 |
|
|
2020
Q4 | $695K | Buy |
+17,299
| New | +$695K | 0.26% | 89 |
|